(secondQuint)Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population.

 Edwards SAPIEN XT cent Transcatheter Heart Valve and NovaFlex+ delivery system will be used for this study.

 A maximum of 60 patients with symptomatic severe calcific aortic stenosis requiring transcatheter aortic valve implantation (TAVI), who are considered high risk for surgical valve replacement who receive a SAPIEN XT THV.

.

 Safety and Effectiveness of Edwards Lifesciences SAPIEN XT THV in the Chinese Population@highlight

To evaluate the safety and effectiveness of the SAPIEN XT (Edwards Lifesciences, Irvine, California) transcatheter heart valve implantation (TAVI) in Chinese patients with symptomatic severe calcific aortic stenosis who are considered at high risk for surgical valve replacement.

